Sign in
Explore the registryTrack Axicabtagene ciloleucel's trials

ZUMA-22

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

Axicabtagene CiloleucelOngoingActive not recruitingPhase 3Open NCT05371093 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…